Evidence map›Paper›PMID 27711183›Full record

ArticlePLoS pathogens2016

XRN1 Is a Species-Specific Virus Restriction Factor in Yeasts.

Paul A Rowley, Brandon Ho, Sarah Bushong, Arlen Johnson, Sara L Sawyer

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. The evolutionary ecology of fungal killer phenotypes.Proceedings. Biological sciences · 2023
    Review
  13. Article
  14. Diverse yeast antiviral systems prevent lethal pathogenesis caused by the L-A mycovirus.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Adaptive Response ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Paul A RowleyBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, United States of America.
Brandon HoSection of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
Sarah BushongSection of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
Arlen JohnsonSection of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
Sara L SawyerBioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, United States of America.
The University of Texas at Austin · USUniversity of Colorado Boulder · US

Funding

MRNA DEGRADATION AND TRANSLATION CONTROL IN YEASTR01GM053655 · NIGMS · UNIVERSITY OF TEXAS AUSTIN · PI JOHNSON, ARLEN W · 1995 to 2017
$5.1M
Rapid evolution of genes critical for genome integrityR01GM093086 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI SAWYER, SARA · 2010 to 2016
$1.9M
NIGMS NIH HHS R01 GM053655NIGMS NIH HHS R01 GM093086
6 · The paper itself

Abstract

In eukaryotes, the degradation of cellular mRNAs is accomplished by Xrn1 and the cytoplasmic exosome. Because viral RNAs often lack canonical caps or poly-A tails, they can also be vulnerable to degradation by these host exonucleases. Yeast lack sophisticated mechanisms of innate and adaptive immunity, but do use RNA degradation as an antiviral defense mechanism. One model is that the RNA of yeast viruses is subject to degradation simply as a side effect of the intrinsic exonuclease activity of proteins involved in RNA metabolism. Contrary to this model, we find a highly refined, species-specific relationship between Xrn1p and the "L-A" totiviruses of different Saccharomyces yeast species. We show that the gene XRN1 has evolved rapidly under positive natural selection in Saccharomyces yeast, resulting in high levels of Xrn1p protein sequence divergence from one yeast species to the next. We also show that these sequence differences translate to differential interactions with the L-A virus, where Xrn1p from S. cerevisiae is most efficient at controlling the L-A virus that chronically infects S. cerevisiae, and Xrn1p from S. kudriavzevii is most efficient at controlling the L-A-like virus that we have discovered within S. kudriavzevii. All Xrn1p orthologs are equivalent in their interaction with another virus-like parasite, the Ty1 retrotransposon. Thus, the activity of Xrn1p against totiviruses is not simply an incidental consequence of the enzymatic activity of Xrn1p, but rather Xrn1p co-evolves with totiviruses to maintain its potent antiviral activity and limit viral propagation in Saccharomyces yeasts. Consistent with this, we demonstrated that Xrn1p physically interacts with the Gag protein encoded by the L-A virus, suggesting a host-virus interaction that is more complicated than just Xrn1p-mediated nucleolytic digestion of viral RNAs.

Indexed as

Blotting, WesternExoribonucleasesHost-Parasite InteractionsImmunoprecipitationPolymerase Chain ReactionRNA, ViralSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTotivirusExoribonucleasesRNA, ViralSaccharomyces cerevisiae ProteinsXRN1 protein, S cerevisiae

Identifiers

PMID27711183
PMCPMC5053509
OpenAlexW2949224746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.